Squarepoint’s Insmed INSM Stock Holding History

Squarepoint’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.6M	Buy	138,300 +134,100	+3,193%	+$20.6M	0.03%	642
2025 Q4	$731K	Sell	4,200 -3,100	-42%	-$566K	﹤0.01%	2880
2025 Q3	$1.05M	Sell	7,300 -1,300	-15%	-$159K	﹤0.01%	2652
2025 Q2	$866K	Buy	+8,600	New	+$658K	﹤0.01%	2793
2025 Q1	–	Sell	-30,800	Closed	-$2.13M	–	4986
2024 Q4	$2.13M	Buy	+30,800	New	+$2.22M	﹤0.01%	2349

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Squarepoint's INSM Position: Q1 2026 in Review

Squarepoint reduced its Insmed (INSM) stake by 41% in Q1 2026, selling an estimated $4.16M and leaving 39,316 shares worth $6.43M. The position accounts for 0.01% of the portfolio, ranked #1328.

Squarepoint first reported a position in INSM in Q4 2015 and has held it in 26 quarters since. The position peaked at $35.5M in Q3 2024. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Squarepoint held 39,316 shares of Insmed worth $6.43M as of Q1 2026.
Squarepoint sold 27,086 Insmed shares in Q1 2026, an estimated $4.16M.
Insmed made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1328 holding.
Squarepoint first reported a position in Insmed in Q4 2015 and has held it in 26 quarters since.
Squarepoint's Insmed position peaked at $35.5M in Q3 2024.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.